Cardiac Syndrome X and Microvascular Coronary Dysfunction

Trends in Cardiovascular Medicine

Volumn 22, Issue 6, 2012, Pages 161-168

  Jones, Erika ^a   Eteiba, Wafia ^b   Merz, Noel Bairey ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; ATORVASTATIN PLUS RAMIPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DILTIAZEM; ENALAPRIL; ENDOTHELIN 1; LIDOFLAZINE; METHACHOLINE; METHYLERGOMETRINE; NICORANDIL; NIFEDIPINE; NITRATE; NITRIC OXIDE; PRAVASTATIN; VERAPAMIL;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; ENDOTHELIAL DYSFUNCTION; HEALTH CARE COST; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; MICROCIRCULATION; NONCARDIAC CHEST PAIN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTON SODIUM EXCHANGE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SYNDROME X; THORAX PAIN; TISSUE DOPPLER IMAGING;

ANGINA PECTORIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MICROCIRCULATION; MICROVASCULAR ANGINA; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 84868281864     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.014     Document Type: Review

References (83)

1. Bairey Merz C.N., Eteiba W., et al. Cardiac syndrome X: Relation to microvascular angina and other conditions. Curr Cardiovasc Rep 2007, 1:167-175.
2. Bairey Merz C.N., Shaw L.J., Reis S.E., et al. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study: Part II. Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006, 47(Suppl 1):S21-S29.
3. Beltrame J.F., Limaye S.B., Horowitz J.D. The coronary slow flow phenomenon-A new coronary microvascular disorder. Cardiology 2002, 97:197-202.
4. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2002, 40:1366-1374.
5. Buchthal S.D., den Hollander J.A., Merz C.N., et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000, 342:829-835.
6. Bugiardini R., Bairey Merz C.N. Angina with "normal" coronary arteries: A changing philosophy. JAMA 2005, 293:477-484.
7. Bugiardini R., Manfrini O., Pizzi C., et al. Endothelial function predicts future development of coronary artery disease: A study of women with chest pain and normal coronary angiograms. Circulation 2004, 109:2518-2523.
8. Burke A., Kolodgie F.D., et al. Gender differences in coronary plaque morphology in sudden coronary death. Circulation 1998, 108:IV-165.
9. Burke A.P., Farb A., et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998, 97:2110-2116.
10. Camici P.G., Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
11. Cannon R.O. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009, 54:877-885.
12. Cannon R.O., Brush J.E., Schenke W.H., et al. Beneficial and detrimental effects of lidoflazine in microvascular angina. Am J Cardiol 1990, 66:37-41.
13. Cannon R.O., Epstein S.E. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988, 61:1338-1343.
14. Cannon R.O., Peden D.B., Berkebile C., et al. Airway hyperresponsiveness in patients with microvascular angina: Evidence for a diffuse disorder of smooth muscle responsiveness. Circulation 1990, 82:2011-2017.
15. Cannon R.O., Quyyumi A.A., Schenke W.H., et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 1990, 16:1359-1366.
16. Cannon R.O., Watson R.M., Rosing D.R., Epstein S.E. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol 1985, 56:242-246.
17. Cavallo Perin P., Pacini G., Giunti S., et al. Microvascular angina (cardiological syndrome X) per se is not associated with hyperinsulinaemia or insulin resistance. Eur J Clin Invest 2000, 30:481-486.
18. Chaudhary I., Kaski J. Cardiac syndrome X: Angina pectoris with normal coronary arteries http://Uptodate.com.
19. Chen J.W., Hsu N.W., Wu T.C., et al. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002, 90:974-982.
20. Chen J.W., Lee W.L., Hsu N.W., et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. Am J Cardiol 1997, 80:32-38.
21. Cosín-Sales J., Pizzi C., Brown S., Kaski J.C. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 2003, 41:1468-1474.
22. Cox I.D., Bøtker H.E., Bagger J.P., et al. Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol 1999, 34:455-460.
23. Davis K.B., Chaitman B., Ryan T., et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: A CASS registry study Coronary Artery Surgery Study. J Am Coll Cardiol 1995, 25:1000-1009.
24. Di Carli M.F., Janisse J., Grunberger G., Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003, 41:1387-1393.
25. Diver D.J., Bier J.D., Ferreira P.E., et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994, 74:531-537.
26. Egashira K., Hirooka Y., Kuga T., et al. Effects of l-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation 1996, 94:130-134.
27. Egashira K., Inou T., Hirooka Y., et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993, 328:1659-1664.
28. Gianni M., Dentali F., Grandi A.M., et al. Apical ballooning syndrome or takotsubo cardiomyopathy: A systematic review. Eur Heart J 2006, 27:1523-1529.
29. Gulli G., Cemin R., Pancera P., et al. Evidence of parasympathetic impairment in some patients with cardiac syndrome X. Cardiovasc Res 2001, 52:208-216.
30. Herrmann J., Higano S.T., Lenon R.J., et al. Myocardial bridging is associated with alteration in coronary vasoreactivity. Eur Heart J 2004, 25:2134-2142.
31. Huang P.H., Chen Y.H., Chen Y.L., et al. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007, 93:1064-1070.
32. Inazumi T., Shimizu H., Mine T., Iwasaki T. Changes in autonomic nervous activity prior to spontaneous coronary spasm in patients with variant angina [in Japanese]. Jpn Circ J 2000, 64:197-201.
33. Jadhav S., Ferrell W., Greer I.A., et al. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006, 48:956-963.
34. Johnson B.D., Shaw L.J., Pepine C.J., et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Eur Heart J 2006, 27:1408-1415.
35. Kaski J.C. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004, 109:568-572.
36. Kaski J.C., Rosano G.M., Collins P., et al. Cardiac syndrome X: Clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995, 25:807-814.
37. Kawano H., Ogawa H. Endothelial function and coronary spastic angina. Intern Med 2005, 44:91-99.
38. Kayikcioglu M., Payzin S., Yavuzgil O., et al. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 2003, 24:1999-2005.
39. Kemp H.G. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973, 32:375-376.
40. Koren W., Koldanov R., Peleg E., et al. Enhanced red cell sodium-hydrogen exchange in microvascular angina. Eur Heart J 1997, 18:1296-1299.
41. Kroenke K., Arrington M.E., Mangelsdorff A.D. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990, 150:1685-1689.
42. La Rovere M.T., Mortara A., Pantaleo P., et al. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation 1994, 90:838-843.
43. Lanza G.A., Giordano A., Pristipino C., et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997, 96:821-826.
44. Lerman A., Burnett J.C., Higano S.T., et al. Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998, 97:2123-2128.
45. Lichtlen P.R., Bargheer K., Wenzlaff P. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings. J Am Coll Cardiol 1995, 25:1013-1018.
46. Mancini G.B. Vascular structure versus function: Is endothelial dysfunction of independent prognostic importance or not?. J Am Coll Cardiol 2004, 43:624-628.
47. Marroquin O.C., Holubkov R., Edmundowicz D., et al. Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice. Am Heart J 2003, 145:628-635.
48. Maseri A., Crea F., Kaski J.C., Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991, 17:499-506.
49. Mieres J.H., Shaw L.J., Arai A., et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005, 111:682-696.
50. Miwa K., Fujita M., Sasayama S. Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm. Heart Vessels 2005, 20:1-7.
51. Mosca L., Banka C.L., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007, 49:1230-1250.
52. Newby D.E., Flint L.L., Fox K.A., et al. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X. J Am Coll Cardiol 1998, 31:1585-1590.
53. Newby L.K., Douglas P.S. Cardiovascular disease in women. Braunwald's heart disease-A textbook of cardiovascular medicine 2011, Saunders Elsevier, Philadelphia, Chapter 81. 9th edition. R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby (Eds.).
54. Opherk D., Zebe H., Weihe E., et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981, 63:817-825.
55. Panting J.R., Gatehouse P.D., Yang G.Z., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002, 346:1948-1953.
56. Pepine C.J., Anderson R.D., Sharaf B.L., et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, lung, and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010, 55:2825-2832.
57. Pepine C.J., Kerensky R.A., Lambert C.R., et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006, 47(Suppl 1):S30-S35.
58. Pepine C.J., Kerensky R.A., et al. Endothelial dysfunction in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 2006, 47(Suppl 1):S30-S35.
59. Pizzi C., Manfrini O., Fontana F., Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: Role of superoxide dismutase activity. Circulation 2004, 109:53-58.
60. Quyyumi A.A., Cannon R.O., Panza J.A., et al. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992, 86:1864-1871.
61. Reaven G.M. Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 1993, 44:121-131.
62. Reis S.E., Holubkov R., Conrad Smith A.J., et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study. Am Heart J 2001, 141:735-741.
63. Richardson P.J., Livesley B., Oram S., et al. Angina pectoris with normal coronary arteries: Transvenous myocardial biopsy in diagnosis. Lancet 1974, 2:677-680.
64. Rosano G.M., Peters N.S., Kaski J.C., et al. Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans. Am J Cardiol 1995, 75:400-402.
65. Rosen S.D., Paulesu E., Wise R.J., Camici P.G. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 2002, 87:513-519.
66. Schächinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
67. Schroeder C., Adams F., Boschmann M., et al. Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am J Physiol Regul Integr Comp Physiol 2004, 286:R851-R856.
68. Shaw L.J., Bairey Merz C.N., Pepine C.J., et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006, 47(3 Suppl):S4-S20.
69. Shaw L.J., Bugiardini R., Merz C.N. Women and ischemic heart disease: Evolving knowledge. J Am Coll Cardiol 2009, 54:1561-1575.
70. Shaw L.J., Merz C.N., Pepine C.J., et al. The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation. Circulation 2006, 114:894-904.
71. Sinici I., Atalar E., Kepez A., et al. Intron 4 VNTR polymorphism of eNOS gene is protective for cardiac syndrome X. J Investig Med 2010, 58:23-27.
72. Sullivan A.K., Holdright D.R., Wright C.A., et al. Chest pain in women: Clinical, investigative, and prognostic features. BMJ 1994, 308:883-886.
73. Sütsch G., Oechslin E., Mayer I., Hess O.M. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int J Cardiol 1995, 52:135-143.
74. Suwaidi J.A., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101:948-954.
75. Takusagawa M., Komori S., Umetani K., et al. Alterations of autonomic nervous activity in recurrence of variant angina. Heart 1999, 82:75-81.
76. Turiel M., Galassi A.R., Glazier J.J., et al. Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris. Am J Cardiol 1987, 60:503-507.
77. Vaccarino V., Badimon L., Corti R., et al. Ischaemic heart disease in women: Are there sex differences in pathophysiology and risk factors?. Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 2011, 90:9-17.
78. Vinereanu D., Fraser A.G., Robinson M., et al. Adenosine provokes diastolic dysfunction in microvascular angina. Postgrad Med J 2002, 78:40-42.
79. von Mering G.O., Arant C.B., Wessel T.R., et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004, 109:722-725.
80. Wiedermann J.G., Schwartz A., Apfelbaum M. Anatomic and physiologic heterogeneity in patients with syndrome X: An intravascular ultrasound study. J Am Coll Cardiol 1995, 25:1310-1317.
81. Wong T.Y., Hubbard L.D., Klein R., et al. Retinal microvascular abnormalities and blood pressure in older people: The Cardiovascular Health Study. Br J Ophthalmol 2002, 86:1007-1013.
82. Zeiher A.M., Drexler H., Wollschläger H., Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991, 84:1984-1992.
83. Zeiher A.M., Krause T., Schächinger V., et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995, 91:2345-2352.